Close Menu

NEW YORK – Horizon Discovery Group reported on Monday that its total revenues as reported for the first half of 2019 rose 14 percent, thanks to large increases in revenues from its bioproduction and screening business units.

For the six months ended June 30, the gene editing and gene modulation technologies company reported total revenues of £28.6 million ($35.6 million), up from £25.1 million in the first half of 2018. On a constant currency basis, revenues rose 9 percent.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Washington Post reports that the CDC's SARS-CoV-2 test issues reflect earlier ones it had with Zika virus testing.

NPR writes that even with thousands of new COVID-19 papers, each should be evaluated based on its own quality.

Researchers traced a gene cluster linked to COVID-19 severity to Neanderthals, the New York Times reports.

In PNAS this week: soil bacteria-derived small molecules affect centrosomal protein, microfluidics approach for capturing circulating tumor cells, and more.